Phase II trial of weekly dose-dense paclitaxel in extensive-stage small cell lung cancer: cancer and leukemia group B study 39901.
- Citation:
- J Thorac Oncol vol 3 (2) 158-62
- Year:
- 2008
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- 807
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- CA114558-02, CA12046, CA16450, CA21060, CA31946, CA33601, CA35113, CA41287, CA45418, CA45808, CA47555, CA47559, CA77440, CA77651
- Corr. Author:
- Authors:
- Stephen L Graziano James E Herndon Mark A Socinski Xiaofei Wang Dorothy Watson Everett Vokes Mark R Green
- Networks:
- Study
- CALGB-39901
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Adult, Aged, Aged, 80 and over, Carcinoma, Small Cell, Dose-Response Relationship, Drug, Drug Administration Schedule, Drug-Related Side Effects and Adverse Reactions, Female, Humans, Infusions, Intravenous, Lung Neoplasms, Male, Paclitaxel, Survival Analysis